相似文献
1
The KT Jeang retrovirology prize 2024: Walther Mothes.
Retrovirology. 2024 Oct 24;21(1):16. doi: 10.1186/s12977-024-00649-8.
2
Erratum to: The KT Jeang Retrovirology prize 2016: Frank Kirchhoff.
Retrovirology. 2016 Sep 16;13(1):69. doi: 10.1186/s12977-016-0303-8.
3
The KT Jeang Retrovirology Prize 2020: call for nominations.
Retrovirology. 2020 Feb 10;17(1):1. doi: 10.1186/s12977-019-0509-7.
4
The KT Jeang Retrovirology prize 2022: Florence Margottin-Goguet.
Retrovirology. 2022 Sep 6;19(1):20. doi: 10.1186/s12977-022-00606-3.
5
The KT Jeang retrovirology prize 2023: Thumbi Ndung'u.
Retrovirology. 2023 Oct 18;20(1):17. doi: 10.1186/s12977-023-00632-9.
6
The KT Jeang Retrovirology prize 2018: Eric Freed.
Retrovirology. 2018 Jul 2;15(1):43. doi: 10.1186/s12977-018-0430-5.
7
The KT Jeang Retrovirology prize 2015: Paul Bieniasz.
Retrovirology. 2015 Oct 5;12:84. doi: 10.1186/s12977-015-0208-y.
8
The KT Jeang Retrovirology prize 2016: Frank Kirchhoff.
Retrovirology. 2016 Aug 5;13(1):53. doi: 10.1186/s12977-016-0286-5.
9
The KT Jeang Retrovirology prize 2017: Michael Emerman.
Retrovirology. 2017 Jun 21;14(1):37. doi: 10.1186/s12977-017-0362-5.
10
The KT Jeang Retrovirology prize 2021: Peter Cherepanov.
Retrovirology. 2021 Sep 27;18(1):28. doi: 10.1186/s12977-021-00573-1.
本文引用的文献
1
Structure and inhibition of SARS-CoV-2 spike refolding in membranes.
Science. 2024 Aug 16;385(6710):757-765. doi: 10.1126/science.adn5658. Epub 2024 Aug 15.
2
Design of soluble HIV-1 envelope trimers free of covalent gp120-gp41 bonds with prevalent native-like conformation.
Cell Rep. 2024 Aug 27;43(8):114518. doi: 10.1016/j.celrep.2024.114518. Epub 2024 Jul 18.
3
Proof-of-concept studies with a computationally designed M inhibitor as a synergistic combination regimen alternative to Paxlovid.
Proc Natl Acad Sci U S A. 2024 Apr 23;121(17):e2320713121. doi: 10.1073/pnas.2320713121. Epub 2024 Apr 15.
4
Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens.
iScience. 2024 Jan 30;27(3):109049. doi: 10.1016/j.isci.2024.109049. eCollection 2024 Mar 15.
5
Intermediate conformations of CD4-bound HIV-1 Env heterotrimers.
Nature. 2023 Nov;623(7989):1017-1025. doi: 10.1038/s41586-023-06639-8. Epub 2023 Nov 22.
6
HIV-1 Env trimers asymmetrically engage CD4 receptors in membranes.
Nature. 2023 Nov;623(7989):1026-1033. doi: 10.1038/s41586-023-06762-6. Epub 2023 Nov 22.
7
Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry.
Nat Commun. 2023 Jul 20;14(1):4368. doi: 10.1038/s41467-023-39262-2.
8
The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice.
Cell Rep Med. 2023 Jan 17;4(1):100893. doi: 10.1016/j.xcrm.2022.100893. Epub 2022 Dec 29.
9
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern.
Cell Rep. 2022 Jan 11;38(2):110210. doi: 10.1016/j.celrep.2021.110210. Epub 2021 Dec 15.
10
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy.
Immunity. 2021 Sep 14;54(9):2143-2158.e15. doi: 10.1016/j.immuni.2021.08.015. Epub 2021 Aug 18.
Zotero 插件